Skip to main content
. 2022 May 20;14(5):1099. doi: 10.3390/pharmaceutics14051099

Table 1.

Composition of the products produced by Screening Methods 1 and 2 based on PXRD.

Additive Screening Method 1 Screening Method 2
ADI Form II PCA + ADI Form I PCA + ADI
CAF No crystal PCA-CAF
CIT Form I PCA Form I PCA
FUM Form II PCA + FUM Form II PCA + FUM
GLU Form I PCA Form I PCA
MAL Form I PCA Form II PCA
MAO Form I PCA Form I PCA
MLC Form I PCA Form II PCA
OXA Form I PCA Form II PCA
SUC Form II PCA Form II PCA
THP PCA-THP + Form II THP PCA-THP + Form II THP
TAR Form I PCA Form I PCA